These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34103321)

  • 21. Annual report on surveillance of adverse events following immunisation in Australia, 2006.
    Lawrence GL; Aratchige PE; Boyd I; McIntyre PB; Gold MS
    Commun Dis Intell Q Rep; 2007 Sep; 31(3):269-82. PubMed ID: 17974219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associations between pharmacy choice and influenza vaccination: Mail order vs community pharmacy users.
    Burbage SC; Parikh MA; Campbell PJ; Ramachandran S; Gatwood J; Ozawa S; Urick BY
    J Manag Care Spec Pharm; 2022 Dec; 28(12):1379-1391. PubMed ID: 36427345
    [No Abstract]   [Full Text] [Related]  

  • 23. Annual report: Surveillance of adverse events following immunisation in Australia, 2011.
    Mahajan D; Cook J; Dey A; Macartney K; Menzies RI
    Commun Dis Intell Q Rep; 2012 Dec; 36(4):E315-32. PubMed ID: 23330706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective cohort study comparing the reactogenicity of trivalent influenza vaccine in pregnant and non-pregnant women.
    Regan AK; Tracey L; Blyth CC; Mak DB; Richmond PC; Shellam G; Talbot C; Effler PV
    BMC Pregnancy Childbirth; 2015 Mar; 15():61. PubMed ID: 25880741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Timeliness of signal detection for adverse events following influenza vaccination in young children: a simulation case study.
    Jacoby P; Glover C; Damon C; Fathima P; Pillsbury A; Durrheim D; Gold MS; Leeb A; Snelling T
    BMJ Open; 2020 Mar; 10(2):e031851. PubMed ID: 32122906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacy, workplace or primary care? Where Australian adults get their influenza vaccines.
    Trent MJ; Salmon DA; MacIntyre CR
    Aust N Z J Public Health; 2021 Aug; 45(4):385-390. PubMed ID: 33818843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An evaluation of the feasibility and usability of a proof of concept mobile app for adverse event reporting post influenza vaccination.
    Wilson K; Atkinson KM; Westeinde J; Bell C; Marty K; Fergusson D; Deeks SL; Crowcroft N; Bettinger JA
    Hum Vaccin Immunother; 2016 Jul; 12(7):1738-48. PubMed ID: 26905396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surveillance of adverse events following immunisation in Australia annual report, 2019.
    Dey A; Wang H; Quinn H; Pillsbury A; Glover C; Hickie M; Wood N; Beard F; Macartney K
    Commun Dis Intell (2018); 2021 Apr; 45():. PubMed ID: 33934694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous active surveillance of adverse events following immunisation using SMS technology.
    Westphal DW; Williams SA; Leeb A; Effler PV
    Vaccine; 2016 Jun; 34(29):3350-5. PubMed ID: 27206385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surveillance of adverse events following immunisation: Australia, 2000-2002.
    Lawrence G; Menzies R; Burgess M; McIntyre P; Wood N; Boyd I; Purcell P; Isaacs D
    Commun Dis Intell Q Rep; 2003; 27(3):307-23. PubMed ID: 14510057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surveillance of adverse events following immunisation in Australia: annual report, 2018.
    Dey A; Wang H; Quinn H; Pillsbury A; Glover C; Hickie M; Wood N; Beard F; Macartney K
    Commun Dis Intell (2018); 2020 Mar; 44():. PubMed ID: 32178607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surveillance of adverse events following immunisation in Australia annual report, 2020.
    Dey A; Wang H; Quinn H; Pillsbury A; Hickie M; Deng L; Wood N; Beard F; Macartney K
    Commun Dis Intell (2018); 2022 Jul; 46():. PubMed ID: 35860867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Annual report: surveillance of adverse events following immunisation in Australia, 2008.
    Menzies R; Mahajan D; Gold MS; Roomiani I; McIntyre P; Lawrence G
    Commun Dis Intell Q Rep; 2009 Dec; 33(4):365-81. PubMed ID: 20301966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parental views on vaccine safety and future vaccinations of children who experienced an adverse event following routine or seasonal influenza vaccination in 2010.
    Parrella A; Gold M; Marshall H; Braunack-Mayer A; Watson M; Baghurst P
    Hum Vaccin Immunother; 2012 May; 8(5):662-7. PubMed ID: 22634441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaxtracker: Active on-line surveillance for adverse events following inactivated influenza vaccine in children.
    Cashman P; Moberley S; Dalton C; Stephenson J; Elvidge E; Butler M; Durrheim DN
    Vaccine; 2014 Sep; 32(42):5503-8. PubMed ID: 25077424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse events following immunization (AEFI) with the novel influenza a (H1N1) 2009 vaccine: findings from the national registry of all vaccine recipients and AEFI and the passive surveillance system in South Korea.
    Kim JH; Cho HY; Hennessey KA; Lee HJ; Bae GR; Kim HC
    Jpn J Infect Dis; 2012; 65(2):99-104. PubMed ID: 22446114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A national examination of pharmacy-based immunization statutes and their association with influenza vaccinations and preventive health.
    McConeghy KW; Wing C
    Vaccine; 2016 Jun; 34(30):3463-8. PubMed ID: 27219340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Effect of Sex on the Incidence, Latency, Duration and Perceived Burden of Adverse Events Following Seasonal Influenza Vaccination in the Netherlands.
    Slingerland P; van Hunsel FPAM; Lieber T; van Balveren L; Duijster JW
    Drug Saf; 2023 Dec; 46(12):1323-1334. PubMed ID: 37882905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. National community pharmacy NHS influenza vaccination service in Wales: a primary care mixed methods study.
    Evans AM; Wood FC; Carter B
    Br J Gen Pract; 2016 Apr; 66(645):e248-57. PubMed ID: 26965025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A scoping review of active, participant-centred, digital adverse events following immunization (AEFI) surveillance: A Canadian immunization research network study.
    Psihogios A; Brianne Bota A; Mithani SS; Greyson D; Zhu DT; Fung SG; Wilson SE; Fell DB; Top KA; Bettinger JA; Wilson K
    Vaccine; 2022 Jul; 40(31):4065-4080. PubMed ID: 35680501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.